文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

CORM-2 通过 SNARE/Munc18b 复合物抑制脓毒症血小板 α 颗粒外排

[Suppressive effect of CORM-2 on platelet α-granule exocytosis in sepsis via SNARE/Munc18b complex formation].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2017-01-01
一句话结论体外研究提示 CORM-2 可剂量依赖性抑制 LPS 刺激的血小板 α 颗粒外排,机制可能涉及 SNARE/Munc18b 复合物形成。

该研究从健康志愿者肘静脉采血分离血小板,随机分为对照组、LPS 组、CORM-2 组(10 μmol/L 和 50 μmol/L)及 iCORM-2 组(50 μmol/L),在 37 ℃、95% 湿度、5% CO2 培养箱中孵育。结果显示 LPS 刺激后血小板 α 颗粒内容物 PF4、PDGF-BB、MMP-2 及 P-选择素明显升高,而 CORM-2 可降低上述指标并减少 α 颗粒向血小板质膜聚集。CORM-2 同时抑制 LPS 诱导的 Munc18b、VAMP-8、SNAP-23、STX-11 表达升高及 SNARE/Munc18b 复合物形成,数据呈剂量依赖性变化。作者认为 CORM-2 抑制 LPS 刺激血小板 α 颗粒外排的潜在机制可能涉及 SNARE/Munc18b 复合物形成。

要点

  • LPS(10 mg/L)刺激可升高血小板 α 颗粒内容物 PF4、PDGF-BB、MMP-2 及 P-选择素,CORM-2(10 μmol/L 和 50 μmol/L)可降低上述指标,所有 P < 0.01。
  • CORM-2 降低 LPS 刺激血小板 α 颗粒向质膜聚集的程度(透射电镜与免疫荧光显微镜观察)。
  • CORM-2 抑制 LPS 诱导的 Munc18b、VAMP-8、SNAP-23、STX-11 表达升高及 SNARE/Munc18b 复合物形成,数据呈剂量依赖性变化,所有 P < 0.01。
  • 作者认为 CORM-2 抑制 LPS 刺激血小板 α 颗粒外排的潜在机制可能涉及 SNARE/Munc18b 复合物形成。
  • 该研究为健康志愿者离体血小板实验,结果不能直接外推至脓毒症患者床旁治疗。

适用人群与场景

  • 健康志愿者肘静脉血分离的血小板(离体实验),非脓毒症患者。

处置流程与药物剂量

  • 对照组不做任何处理;LPS 组给予 10 mg/L LPS 模拟;CORM-2 组在 LPS 模拟后立即给予 CORM-2 10 μmol/L 或 50 μmol/L;iCORM-2 组在 LPS 模拟后立即给予 iCORM-2 50 μmol/L。
  • 各组于 37 ℃、95% 湿度、5% CO2 培养箱中孵育。

研究设计与关键结果

  • 研究类型为离体血小板实验,血小板来自健康志愿者肘静脉血,随机分为 5 组。
  • 与对照组比较,LPS 组 PF4(μg/L)10.13±0.82、PDGF-BB(μg/L)128.78±1.39、MMP-2(ng/L)53.26±1.21、P-选择素(23.78±0.62)% 均明显升高。
  • CORM-2 10 μmol/L 组与 50 μmol/L 组分别使 PF4 降至 7.69±0.58、6.03±0.71 μg/L,PDGF-BB 降至 112.71±1.79、102.91±5.86 μg/L,MMP-2 降至 32.94±2.73、27.58±3.36 ng/L,P-选择素降至(17.14±0.57)%、(15.35±0.68)%,均 P < 0.01。
  • 透射电镜与免疫荧光显微镜显示 CORM-2 处理后血小板 α 颗粒向质膜聚集的程度明显降低。
  • 与对照组比较,LPS 刺激血小板 Munc18b/GAPDH 0.99±0.09、VAMP-8/GAPDH 1.18±0.14、SNAP-23/GAPDH 1.90±0.08、STX-11/GAPDH 1.16±0.23、VAMP-8/Munc18b 1.21±0.20、SNAP-23/Munc18b 1.26±0.08、STX-11/Munc18b 1.39±0.16 均显著升高。
  • CORM-2 10 μmol/L 组与 50 μmol/L 组分别使 Munc18b/GAPDH 降至 0.80±0.08、0.69±0.01,VAMP-8/GAPDH 降至 0.72±0.09、0.50±0.12,SNAP-23/GAPDH 降至 1.18±0.22、0.63±0.10,STX-11/GAPDH 降至 0.76±0.02、0.57±0.08,VAMP-8/Munc18b 降至 0.65±0.09、0.53±0.07,SNAP-23/Munc18b 降至 0.85±0.07、0.55±0.09,STX-11/Munc18b 降至 0.78±0.05、0.61±0.10,均 P < 0.01。
  • 上述数据呈剂量依赖性变化。

证据类型、等级与局限

  • 证据类型:离体血小板实验(健康志愿者血标本)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该离体实验提示 CORM-2 可能通过 SNARE/Munc18b 复合物抑制 LPS 刺激的血小板 α 颗粒外排,作者认为此机制可能参与脓毒症血小板活化,但尚未在脓毒症患者中验证。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the suppressive effect of carbon monoxide-releasing molecule II (CORM-2) on LPS induced platelet α-granule exocytosis in sepsis via soluble N-ethylmaleimide-sensitive factor attached protein receptor/mammalian uncoordinated 18b (SNARE/Munc18b) complex formation.

METHODS: Blood was collected from healthy volunteers' cubital vein, then platelets were isolated by differential centrifugation. Platelets were randomly divided into 5 groups. The control group did not undergo any treatment, the LPS group received 10 mg/L LPS simulation, the CORM-2 group and iCORM-2 group underwent LPS simulation and immediate administration of CORM-2 (10 μmol/L and 50 μmol/L) or iCORM-2 (50 μmol/L), respectively. Samples were incubated in a CO2-incubator at 37 °C, 95% humidity, and 5% CO2. Platelet α-granule contents were detected by using standard enzyme linked immunosorbent assay (ELISA), including platelet factor 4 (PF4), platelet derived growth factor-BB (PDGF-BB), and matrix metalloproteinase-2 (MMP-2). The expression of P-selectin was detected by flow cytometer. Transmission electron microscope and immunofluorescence microscope was used to assess platelet α-granules distribution. Expressions of Munc18b and SNARE proteins including vesicle-associated membrane protein-8 (VAMP-8), synaptosomal-associated protein-23 (SNAP-23) and syntaxin-11 (STX-11) were detected by Western Bolt. The SNARE/Munc18b complex formation was detected by immunoprecipitation.

RESULTS: Compared with the control group, levels of PF4, PDGF-BB, MMP-2 and P-selectin in LPS induced platelets were found to markedly elevated, while CORM-2 (10 μmol/L and 50 μmol/L) could decrease platelet α-granule contents exocytosis: [PF4 (μg/L): 7.69±0.58, 6.03±0.71 vs. 10.13±0.82; PDGF-BB (μg/L): 112.71±1.79, 102.91±5.86 vs. 128.78±1.39; MMP-2 (ng/L): 32.94±2.73, 27.58±3.36 vs. 53.26±1.21; P-selectin: (17.14±0.57)%, (15.35±0.68)% vs. (23.78±0.62)%; all P < 0.01]. Transmission electron microscope and immunofluorescence microscope showed that the extent of platelet α-granules assembled to platelet plasma membrane was significantly decreased following CORM-2 treatment. Compared with the control group, the expressions of Munc18b and SNARE proteins and SNARE/Munc18b complex formation in LPS-stimulated platelets were significantly increased, while CORM-2 (10 μmol/L and 50 μmol/L) inhibited these elevations (Munc18b/GAPDH: 0.80±0.08, 0.69±0.01 vs. 0.99±0.09; VAMP-8/GAPDH: 0.72±0.09, 0.50±0.12 vs. 1.18±0.14; SNAP-23/GAPDH: 1.18±0.22, 0.63±0.10 vs. 1.90±0.08; STX-11/GAPDH: 0.76±0.02, 0.57±0.08 vs. 1.16±0.23; VAMP-8/Munc18b: 0.65±0.09, 0.53±0.07 vs. 1.21±0.20; SNAP-23/Munc18b: 0.85±0.07, 0.55±0.09 vs. 1.26±0.08; STX-11/Munc18b: 0.78±0.05, 0.61±0.10 vs. 1.39±0.16; all P < 0.01). Above all, the data showed a dose dependent change.

CONCLUSIONS: We could suggest that CORM-2 suppressed α-granule exocytosis in LPS-stimulated platelets and the potential mechanisms might involve SNARE/Munc18b complex formation.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhuang M, Sun B, Liu D, et al. [Suppressive effect of CORM-2 on platelet α-granule exocytosis in sepsis via SNARE/Munc18b complex formation]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2017. PMID: 28625264. doi:10.3760/cma.j.issn.2095-4352.2017.02.012

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。